Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.9 |
mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0073 | 0.9 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0044 | 0.9 |